Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-II for knee osteoarthritis: randomized placebo-controlled trial
DRKS00028473Phase 4Not yet recruiting
- Sponsor
- Orthopädie im Mediapark
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in knee osteoarthritis (OA) comparing UC-II 40 mg daily with Placebo (2 arms). Planned start Mar 2022; status: not yet recruiting.
02
Drugs
collagen type ii
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on DRKS00028473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00028473.